title: [Tadalafil for erectile dysfunction: excellent safety and tolerance].
abstract: As a novel phosphodiesterase type 5 (PDE5) inhibitor, tadalafil is administered orally for the treatment of erectile dysfunction (ED). In addition to its outstanding efficacy that lasts 36 hours, tadalafil shows an excellent safety and tolerance, with only a few transient mild to moderate adverse events. Usually ED patients are concomitantly afflicted with multiple pre-existing medical conditions or receive a range of drugs at the same time. Therefore, it is essential to understand its safety in general population and some special high-risk cohorts.
authors.affiliation: Research Institute for Male Health, Peking University People's Hospital, Beijing 100044, China. bai-wj@163.com
authors.forename: Wen-Jun
authors.initials: WJ
authors.lastname: Bai
mesh_terms: D002243:Carbolines / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000068581:Tadalafil
chemical_list: D002243:Carbolines; D010726:Phosphodiesterase Inhibitors; D000068581:Tadalafil